Starting in June, Weibo said that the liver began to build positions in the large A shares, and the returns are still okay. The entry point is not the best, but it is also a relatively suitable time to enter.

This is actually a bull market for the repricing of China's core assets. Unfortunately, the liver didn't play much in the stock market before and has no experience, and by the time I reacted, the layout was already completed.

It's not the best layout, but I still hope for a good outcome.